Search Results

There are 227 results for: content related to: Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer

  1. You have free access to this content
    Identification of a novel point mutation in ENT1 that confers resistance to Ara-C in human T cell leukemia CCRF-CEM cells

    FEBS Letters

    Volume 583, Issue 2, January 22, 2009, Pages: 425–429, Eric I. Zimmerman, Min Huang, Andrea V. Leisewitz, Yanhong Wang, Jing Yang and Lee M. Graves

    Version of Record online : 29 DEC 2008, DOI: 10.1016/j.febslet.2008.12.041

  2. You have free access to this content
    The prognostic significance of human equilibrative nucleoside transporter 1 expression in patients with metastatic bladder cancer treated with gemcitabine-cisplatin-based combination chemotherapy

    BJU International

    Volume 108, Issue 2b, July 2011, Pages: E110–E116, Nagahide Matsumura, Yasushi Nakamura, Yasuo Kohjimoto, Takeshi Inagaki, Yoshihito Nanpo, Hironao Yasuoka, Yasuo Ohashi and Isao Hara

    Version of Record online : 16 DEC 2010, DOI: 10.1111/j.1464-410X.2010.09932.x

  3. New role of the human equilibrative nucleoside transporter 1 (hENT1) in Epithelial-to-mesenchymal transition in renal tubular cells

    Journal of Cellular Physiology

    Volume 227, Issue 4, April 2012, Pages: 1521–1528, Elena Guillén-Gómez, Itziar Pinilla-Macua, Sandra Pérez-Torras, Doo-Sup Choi, Yolanda Arce, José A. Ballarín, Marçal Pastor-Anglada and Montserrat M. Díaz-Encarnación

    Version of Record online : 11 JAN 2012, DOI: 10.1002/jcp.22869

  4. You have free access to this content
    PKC regulation of the human equilibrative nucleoside transporter, hENT1

    FEBS Letters

    Volume 517, Issue 1-3, April 24, 2002, Pages: 201–205, Imogen Coe, Ying Zhang, Tamara McKenzie and Zlatina Naydenova

    Version of Record online : 7 APR 2002, DOI: 10.1016/S0014-5793(02)02622-4

  5. Nitric oxide reduces adenosine transporter ENT1 gene (SLC29A1) promoter activity in human fetal endothelium from gestational diabetes

    Journal of Cellular Physiology

    Volume 208, Issue 2, August 2006, Pages: 451–460, Marcelo Farías, Rody San Martín, Carlos Puebla, Jeremy D. Pearson, Javier F. Casado, Marçal Pastor-Anglada, Paola Casanello and Luis Sobrevia

    Version of Record online : 10 MAY 2006, DOI: 10.1002/jcp.20680

  6. Human equilibrative nucleoside transporter 1 testing in pancreatic ductal adenocarcinoma: a comparison between murine and rabbit antibodies

    Histopathology

    Volume 66, Issue 3, February 2015, Pages: 457–462, Magali Svrcek, Jérôme Cros, Raphael Maréchal, Jean-Baptiste Bachet, Jean-François Fléjou and Pieter Demetter

    Version of Record online : 22 DEC 2014, DOI: 10.1111/his.12577

  7. You have free access to this content
    Excision repair cross-complementing gene-1, ribonucleotide reductase subunit M1, ribonucleotide reductase subunit M2, and human equilibrative nucleoside transporter-1 expression and prognostic value in biliary tract malignancy

    Cancer

    Volume 119, Issue 2, 15 January 2013, Pages: 454–462, Sarah B. Fisher, Kevin E. Fisher, Sameer H. Patel, Matthew G. Lim, David A. Kooby, Bassel F. El-Rayes, Charles A. Staley III, N. Volkan Adsay, Alton B. Farris III and Shishir K. Maithel

    Version of Record online : 3 JUL 2012, DOI: 10.1002/cncr.27739

  8. High D-glucose reduces SLC29A1 promoter activity and adenosine transport involving specific protein 1 in human umbilical vein endothelium

    Journal of Cellular Physiology

    Volume 215, Issue 3, June 2008, Pages: 645–656, Carlos Puebla, Marcelo Farías, Marcelo González, Andrea Vecchiola, Claudio Aguayo, Bernardo Krause, Marçal Pastor-Anglada, Paola Casanello and Luis Sobrevia

    Version of Record online : 6 DEC 2007, DOI: 10.1002/jcp.21347

  9. Human equilibrative nucleoside transporter 1 expression is a strong independent prognostic factor in UICC T3—T4 pancreatic cancer patients treated with preoperative gemcitabine-based chemoradiotherapy

    Journal of Hepato-Biliary-Pancreatic Sciences

    Volume 19, Issue 4, July 2012, Pages: 413–425, Yasuhiro Murata, Takashi Hamada, Masashi Kishiwada, Ichiro Ohsawa, Shugo Mizuno, Masanobu Usui, Hiroyuki Sakurai, Masami Tabata, Noriko Ii, Hiroyuki Inoue, Taizo Shiraishi and Shuji Isaji

    Version of Record online : 7 SEP 2011, DOI: 10.1007/s00534-011-0440-3

  10. You have free access to this content
    An analysis of human equilibrative nucleoside transporter-1, ribonucleoside reductase subunit M1, ribonucleoside reductase subunit M2, and excision repair cross-complementing gene-1 expression in patients with resected pancreas adenocarcinoma

    Cancer

    Volume 119, Issue 2, 15 January 2013, Pages: 445–453, Sarah B. Fisher, Sameer H. Patel, Pelin Bagci, David A. Kooby, Bassel F. El-Rayes, Charles A. Staley III, N. Volkan Adsay and Shishir K. Maithel

    Version of Record online : 8 MAY 2012, DOI: 10.1002/cncr.27619

  11. You have free access to this content
    Role of adenosine transport in gestational diabetes-induced l-arginine transport and nitric oxide synthesis in human umbilical vein endothelium

    The Journal of Physiology

    Volume 560, Issue 1, October 2004, Pages: 111–122, Gustavo Vásquez, Felipe Sanhueza, Rodrigo Vásquez, Marcelo González, Rody San Martín, Paola Casanello and Luis Sobrevia

    Version of Record online : 5 OCT 2004, DOI: 10.1113/jphysiol.2004.068288

  12. Emerging Transporters of Clinical Importance: An Update From the International Transporter Consortium

    Clinical Pharmacology & Therapeutics

    Volume 94, Issue 1, July 2013, Pages: 52–63, K M Hillgren, D Keppler, A A Zur, K M Giacomini, B Stieger, C E Cass, L Zhang and International Transporter Consortium

    Version of Record online : 8 APR 2013, DOI: 10.1038/clpt.2013.74

  13. Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer

    Journal of Cellular Physiology

    Volume 223, Issue 2, May 2010, Pages: 384–388, Daniele Santini, Bruno Vincenzi, Maria Elisabetta Fratto, Giuseppe Perrone, Raymond Lai, Vincenzo Catalano, Carol Cass, Pier Adelchi Ruffini, Chiara Spoto, Pietro Muretto, Sergio Rizzo, Andrea Onetti Muda, John R. Mackey, Antonio Russo, Giuseppe Tonini and Francesco Graziano

    Version of Record online : 15 JAN 2010, DOI: 10.1002/jcp.22045

  14. Insulin restores glucose inhibition of adenosine transport by increasing the expression and activity of the equilibrative nucleoside transporter 2 in human umbilical vein endothelium

    Journal of Cellular Physiology

    Volume 209, Issue 3, December 2006, Pages: 826–835, Gonzalo Muñoz, Rody San Martín, Marcelo Farías, Luis Cea, Andrea Vecchiola, Paola Casanello and Luis Sobrevia

    Version of Record online : 21 AUG 2006, DOI: 10.1002/jcp.20769

  15. Immunohistochemical expression profiles of solute carrier transporters in alpha-fetoprotein-producing gastric cancer

    Histopathology

    Takaaki Shimakata, Shingo Kamoshida, Jumpei Kawamura, Naoki Ogane, Yoichi Kameda, Emmy Yanagita, Tomoo Itoh, Risa Takeda, Ayano Naka, Kuniko Sakamaki, Yurie Hayashi and Sadahito Kuwao

    Version of Record online : 25 JUL 2016, DOI: 10.1111/his.13004

  16. Human equilibrative nucleoside transporter 1 level does not predict prognosis in pancreatic cancer patients treated with neoadjuvant chemoradiation including gemcitabine

    Journal of Hepato-Biliary-Pancreatic Sciences

    Volume 19, Issue 6, November 2012, Pages: 717–722, Natsuko Kawada, Hiroyuki Uehara, Kazuhiro Katayama, Satoaki Nakamura, Hidenori Takahashi, Hiroaki Ohigashi, Osamu Ishikawa, Shigenori Nagata and Yasuhiko Tomita

    Version of Record online : 17 MAR 2012, DOI: 10.1007/s00534-012-0514-x

  17. You have free access to this content
    Transgenic expression of human equilibrative nucleoside transporter 1 in mouse neurons

    Journal of Neurochemistry

    Volume 109, Issue 2, April 2009, Pages: 562–572, Fiona E. Parkinson, Wei Xiong, Christina R. Zamzow, Taeyo Chestley, Tooru Mizuno and Mary Lynn Duckworth

    Version of Record online : 13 FEB 2009, DOI: 10.1111/j.1471-4159.2009.05991.x

  18. You have free access to this content
    Expression of the nucleoside-derived drug transporters hCNT1, hENT1 and hENT2 in gynecologic tumors

    International Journal of Cancer

    Volume 112, Issue 6, 20 December 2004, Pages: 959–966, Xavier Farré, Elena Guillén-Gómez, Lydia Sánchez, David Hardisson, Yolanda Plaza, Jorge Lloberas, F. Javier Casado, José Palacios and Marçal Pastor-Anglada

    Version of Record online : 18 AUG 2004, DOI: 10.1002/ijc.20524

  19. Clinical application of the biomarkers for the selection of adjuvant chemotherapy in pancreatic ductal adenocarcinoma

    Journal of Hepato-Biliary-Pancreatic Sciences

    Volume 23, Issue 8, August 2016, Pages: 480–488, Atsushi Oba, Daisuke Ban, Susumu Kirimura, Keiichi Akahoshi, Yusuke Mitsunori, Satoshi Matsumura, Takanori Ochiai, Atsushi Kudo, Shinji Tanaka and Tanabe Minoru

    Version of Record online : 23 JUN 2016, DOI: 10.1002/jhbp.366

  20. Synthesis of Purine and 7-Deazapurine Nucleoside Analogues of 6-N-(4-Nitrobenzyl)adenosine; Inhibition of Nucleoside Transport and Proliferation of Cancer Cells

    ChemMedChem

    Volume 9, Issue 9, September 2014, Pages: 2186–2192, Ramanjaneyulu Rayala, Patricia Theard, Heysell Ortiz, Dr. Sylvia Yao, Prof. James D. Young, Prof. Jan Balzarini, Prof. Morris J. Robins and Prof. Stanislaw F. Wnuk

    Version of Record online : 30 APR 2014, DOI: 10.1002/cmdc.201402047